Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
LHRH Agonists Show Considerable Promise In Early Breast Cancer
http://www.medicalnewstoday.com/articles/124763.php
Women who have had early stage breast cancer surgically removed, and whose tumour cells are stimulated by the hormone oestrogen, can benefit from taking Luteinizing hormone releasing hormone (LHRH) antagonists, a Cochrane Systematic Review has concluded.
Testing Interactions Of Black Cohosh And Tamoxifen Using Unique Model Of Breast Cancer
http://www.medicalnewstoday.com/articles/124733.php
When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer.
Anti-Inflammatory Drugs Associated With Reduced Breast Cancer Risk In Largest Review Of Its Kind
http://www.medicalnewstoday.com/articles/124725.php
Analysis of data from 38 studies that enrolled more than 2.7 million women - the largest of its kind - by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 per cent relative risk reduction in breast cancer compared to non-users.
Tamoxifen Chemoprevention Associated With Earlier Diagnosis Of ER-Negative Breast Cancer
http://www.medicalnewstoday.com/articles/124713.php
Women at elevated risk of breast cancer who had been randomly assigned to tamoxifen treatment and then developed estrogen receptor (ER)-negative breast cancer were diagnosed earlier than women who had been randomly assigned to take a placebo and then developed ER-negative disease, according to a study published online October 7 in the <i>Journal of the National Cancer Institute.
News From The Journal Of The National Cancer Institute, Oct. 7
http://www.medicalnewstoday.com/articles/124703.php
<b>Study Design Proposed to Improve Biomarker Development</b>Researchers propose a nested case-control study design aimed at determining the accuracy of biomarker classification. The new design is called PRoBE for prospective-specimen-collection and retrospective-blinded-evaluation.
Medipattern's B-CAD(R) Increases Diagnostic Accuracy On Small Breast Cancer Lesions By 44%
http://www.medicalnewstoday.com/articles/124632.php
The Medipattern Corporation (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that a study abstract, showing a statistically significant increase in diagnostic accuracy when using B-CAD Version 2 on lesions less than 1 cm in size, has been published in the October 2008 issue of the<i> American Journal of Clinical Oncology.
Biological 3-D Problem Solved By Egg Whites
http://www.medicalnewstoday.com/articles/124619.php
The real world is three-dimensional. That's true even in the laboratory, where scientists have to grow cells to study how they develop and what happens when their growth is abnormal.More and more laboratories are seeking to develop three-dimensional cell culture systems that allow them to test their new techniques and drugs in a system that more closely mimics the way in which cells grow.
Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage Of Its Second Bavituximab Phase II Breast Cancer Trial
http://www.medicalnewstoday.com/articles/124594.php
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced that it has completed enrollment in the first stage of a Phase II trial of bavituximab in combination with chemotherapy in patients with advanced breast cancer.
----------------------------------------------
** CANCER / ONCOLOGY News **
What Is The Influence Of Tumor Removal On The Serum Level Of Carbohydrate's Antibody?
http://www.medicalnewstoday.com/articles/124783.php
Cancer immune surveillance is considered to be important in the anti-tumor protection of the host. The growing tumor escapes the immune control under the immunosuppressive conditions. The surgical removal of the tumor may reverse the immunosuppression.
National Cancer Institute Again Awards Competitive Grant To Indiana University Melvin And Bren Simon Cancer Center
http://www.medicalnewstoday.com/articles/124782.php
The Indiana University Melvin and Bren Simon Cancer Center has been recognized as a premier cancer center for the third consecutive time by the National Cancer Institute. Since 1999, the IU Simon Cancer Center has carried the prestigious NCI designation.
Neotropix(R) Announces Expansion Of On-going Clinical Trial For Adult Neuroendocrine Cancers
http://www.medicalnewstoday.com/articles/124759.php
Neotropix®, Inc., a clinical-stage development company focused on neuroendocrine cancer treatments, announced today that it has begun enrolling neuroendocrine cancer patients into an expanded clinical trial of its lead candidate, NTX-010 (SVV-001), a tumor-selective naturally-occurring oncolytic virus.
Gut Reaction To Arsenic Exposure Simulated By Scientists
http://www.medicalnewstoday.com/articles/124721.php
A simulated gastrointestinal system is helping scientists test contaminated soil for its potential to harm humans. The method is likely to save time and money for people hoping to repurpose land with an industrial past.
Sorafenib Treatment Appears To Benefit Older Renal Cancer Patients
http://www.medicalnewstoday.com/articles/124708.php
Older and younger patients with renal cancer derive similar benefit from sorafenib therapy and tolerate the drug equally well, according to a study published online October 7 in the <i>Journal of the National Cancer Institute.
PET Scans In Oncology - Not Always The Answer
http://www.medicalnewstoday.com/articles/124704.php
More than 90 percent of PET scans worldwide are now used for oncology indications. PET scans are more accurate than "conventional" imaging in a range of cancers, according to Dr Aravind Ravi Kumar from the Royal Brisbane and Women's Hospital.
Wall Street Journal Examines Cultural Taboos That Influence Minority Patients' Cancer Care
http://www.medicalnewstoday.com/articles/124701.php
The <cite>Wall Street Journal</cite> on Saturday profiled the <a href="http://www.maimonidesmed.org/body.cfm?id=77" target="_new">Maimonides Cancer Center</a> in the Chinatown section of Brooklyn, N.
Increase In Size Of Ozone Hole
http://www.medicalnewstoday.com/articles/124676.php
The 2008 ozone hole - a thinning in the ozone layer over Antarctica - is larger both in size and ozone loss than 2007 but is not as large as 2006.Ozone is a protective atmospheric layer found in about 25 kilometres altitude that acts as a sunlight filter shielding life on Earth from harmful ultraviolet rays, which can increase the risk of skin cancer and cataracts and harm marine life.
DFG President Congratulates Harald Zur Hausen On The Nobel Prize For Medicine
http://www.medicalnewstoday.com/articles/124672.php
The President of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Professor Matthias Kleiner, has congratulated the Heidelberg cancer researcher, Professor Harald zur Hausen, on being awarded this year's Nobel Prize for Medicine.
Turning Cancer Friend Into Cancer Foe
http://www.medicalnewstoday.com/articles/124643.php
Burnham Institute for Medical Research has announced that scientists have created a peptide that binds to Bcl-2, a protein that protects cancer cells from programmed cell death, and converts it into a cancer cell killer.
Journal Of Biological Chemistry Article Gives Insight Into Molecular Mechanisms That Influence Tumor Progression And Metastasis
http://www.medicalnewstoday.com/articles/124642.php
The research group led by the University of Nebraska Medical Center's Tony Hollingsworth, Ph.D., is known to tackle complex scientific problems. Their latest discovery sheds light on how tumor cells interact and survive during the process of metastasis, when they end up in unusual environments (such as when a cell from the pancreas colonizes the liver).
Cancer Research UK Forges Links With Sony BMG And Live Nation For Abbey Road Event 'Sound & Vision'
http://www.medicalnewstoday.com/articles/124620.php
Cancer Research UK has announced that Sound & Vision, its annual heritage music event, is being sponsored by Sony BMG, Live Nation and Sound Advice in 2009. The move comes after Sony BMG, the major music entertainment company and Live Nation, the world's leading concert promoter, both named Cancer Research UK as their charity of the year.
CEL-SCI Enters Agreement With National Institutes Of Health Clinical Center To Determine The Molecular Basis Of Multikine Anti Tumor Effect
http://www.medicalnewstoday.com/articles/124581.php
CEL-SCI Corporation (NYSE: CVM) announced that it has entered into a Material Transfer Agreement (MTA) with the National Institutes of Health Clinical Center (NIHCC) and the laboratory of Dr.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Young, Insured Cancer Patient's Parents Risk Bankruptcy For Treatment
http://www.medicalnewstoday.com/articles/124789.php
"I was 20 and knew I needed to pay a visit to my gynecologist because it is something very important for women to do, of course. I did go and I was given a routine pap smear," said Crystal Wagner of Grayson, Ga.
DFG President Congratulates Harald Zur Hausen On The Nobel Prize For Medicine
http://www.medicalnewstoday.com/articles/124672.php
The President of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Professor Matthias Kleiner, has congratulated the Heidelberg cancer researcher, Professor Harald zur Hausen, on being awarded this year's Nobel Prize for Medicine.
Researcher Wins Nobel Prize For Discovering HPV, Cervical Cancer Link
http://www.medicalnewstoday.com/articles/124637.php
<BR />Harald zur Hausen, the German researcher who discovered the human papillomavirus, was awarded half of the $1.4 million Nobel Prize in Medicine on Monday, the <A href="http://www.nytimes.
----------------------------------------------
** COLORECTAL CANCER News **
Biothera Completes Enrollment Of First Arm Of Metastatic Colorectal Cancer Trial
http://www.medicalnewstoday.com/articles/124728.php
Biothera announced today that it completed enrollment in the first arm of its metastatic colorectal cancer (mCRC) trial in July. The dual-arm trial is evaluating the combination therapy of Imprime PGG®, the company's lead drug candidate, and Erbitux® (cetuximab), a monoclonal antibody from ImClone Systems, with or without chemotherapy.
Mayo Clinic Estimates New, Tiny, Super-sensitive Probe Could Cut Colon Polyp Removal In Half
http://www.medicalnewstoday.com/articles/124716.php
Based on results of a landmark study, researchers at Mayo Clinic's Florida campus see a future in which virtual biopsies will eliminate the need to remove colon polyps that are not cancerous or will not morph into the disease.
----------------------------------------------
** LUNG CANCER News **
Novel Lung Cancer Vaccine Trial Launched At Moores UCSD Cancer Center
http://www.medicalnewstoday.com/articles/124727.php
Oncologists at the Moores Cancer Center at the University of California, San Diego (UCSD) in La Jolla are hoping to stave off the relentless march of advanced lung cancer by treating patients with a novel kind of cancer vaccine.
Roswell Park Physician To Lead National Study For Patients With Advanced Lung Cancer
http://www.medicalnewstoday.com/articles/124631.php
Alex A. Adjei, MD, PhD, Senior Vice President of Clinical Research and the Katherine Anne Gioia Chair in Cancer Medicine at <a href="http://www.roswellpark.org" target="_blank" rel="nofollow">Roswell Park Cancer Institute</a> is the chair of a newly-launched national clinical trial: the first ever to determine if biomarkers can help guide therapies for lung cancer.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Center For Prostate Disease Research Reports New Prognostic Utility Of PCA3 Molecular Urine Test
http://www.medicalnewstoday.com/articles/124602.php
In a recent report, the collaborative research team from the Center for Prostate Disease Research at the Uniformed Services Universit of the Health Sciences (USU) and Walter Reed Army Medical Center (WRAMC) and Gen-Probe Inc.
Researchers Unravel New Aspects Of The Male Hormone (Androgen) Receptor Regulation In Prostate Cancer
http://www.medicalnewstoday.com/articles/124601.php
A team of researchers in the Center for Prostate Disease Research (CPDR) at the Uniformed Services University of the Health Sciences (USU), led by Dr. Shiv Srivastava, professor of surgery, are working to define male hormone regulated transcriptome in prostate cancer cells.
Researchers Provide New Insights Into Common Alterations Of ERG Oncogene In Prostate Cancer
http://www.medicalnewstoday.com/articles/124600.php
In the past three years, ground-breaking discoveries in the prostate cancer field have highlighted that alterations of ETS related genes (predominantly ERG), as a result of a fusion between male hormone receptor regulated gene promoters (predominantly TMPRSS2) and ETS transcription factors, represent one of the most common oncogenic defects in prostate cancer.
BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
http://www.medicalnewstoday.com/articles/124589.php
BN ImmunoTherapeutics has now evaluated the mature Phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership with the National Cancer Institute (NCI) in the US.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment